These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Attenuation of pilocarpine-induced hypothermia in response to chronic administration of choline. Pomara N; Block R; Demetriou S; Fucek F; Stanley M; Gershon S Psychopharmacology (Berl); 1983; 80(2):129-30. PubMed ID: 6410440 [TBL] [Abstract][Full Text] [Related]
11. Choline in Alzheimers disease. Levy R Lancet; 1978 Oct; 2(8096):944-5. PubMed ID: 81959 [No Abstract] [Full Text] [Related]
12. Chronic treatment with choline or scopolamine indicates the presence of muscarinic cholinergic receptor plasticity in the frontal cortex of young but not of aged mice. Pilch H; Müller WE J Neural Transm; 1988; 71(1):39-43. PubMed ID: 3343594 [TBL] [Abstract][Full Text] [Related]
14. Neurochemical approaches to the treatment of senile dementia. Growdon JH; Corkin S Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654 [No Abstract] [Full Text] [Related]
15. The utility of muscarinic agonists in the treatment of Alzheimer's disease. Messer WS J Mol Neurosci; 2002; 19(1-2):187-93. PubMed ID: 12212779 [TBL] [Abstract][Full Text] [Related]
16. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998 [TBL] [Abstract][Full Text] [Related]
17. Choline in Alzheimer's disease. Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636 [No Abstract] [Full Text] [Related]
18. [Influence of choline on amnesia in Alzheimer's disease (author's transl)]. Whiteley A; Signoret JL; Agid Y; Lhermitte F Rev Neurol (Paris); 1979 Oct; 135(8-9):565-72. PubMed ID: 531411 [TBL] [Abstract][Full Text] [Related]
19. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. McKinney M; Coyle JT Mayo Clin Proc; 1991 Dec; 66(12):1225-37. PubMed ID: 1749291 [TBL] [Abstract][Full Text] [Related]
20. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease. Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]